Top Markets
#1 Tornado Cash Tornado Cash +6.24%
#2 Story Story +5.52%
#3 UnifAI Network UnifAI Network +4.47%
#4 TENDIES TENDIES +3.59%
#5 Ontology Gas Ontology Gas +3.51%
#6 Seeker Seeker +2.82%
#7 Orochi Network Orochi Network +2.79%
#8 Dual Dual +2.79%
#9 Figure Heloc Figure Heloc +2.55%
#10 HOME HOME +2.38%
Coin of the day
Tornado Cash Tornado Cash
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Myriad Genetics, Inc. Myriad Genetics, Inc.

Myriad Genetics, Inc.

MYGN
Classificação em ações #16435
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company,... Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
Preço da ação
$3.12
Última sincronização: 2026-09-01
Valor de mercado
$294.21M
Variação (1 dia)
-3.26%
Variação (1 ano)
-54.86%
País
US
Negociar Myriad Genetics, Inc. (MYGN)

Categoria

Healthcare
Histórico de preços das ações de Myriad Genetics, Inc. (MYGN)
Preço de fecho mais alto: $3.12 em 2026-09-01

Preço de fecho mais baixo: $6.26 em 1995-10-01
Histórico de preços das ações da Myriad Genetics, Inc. de 1995 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -18.04%
2025 -52.58%
2024 -26.48%
2023 13.37%
2022 -33.36%
2021 39.65%
2020 -28.26%
2019 -13.46%
2018 -10.65%
2017 93.59%
2016 -59.78%
2015 23.94%
2014 43.88%
2013 -11.52%
2012 33.91%
2011 -9.35%
2010 -9.34%
2009 -21.06%
2008 31.47%
2007 54.75%
2006 52.27%
2005 -8.28%
2004 76.12%
2003 -21.79%
2002 -71.64%
2001 -35.93%
2000 374.80%
1999 284.52%
1998 -60.30%
1997 -0.15%
1996 -23.04%
1995 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $600.47 23.17%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.90 1.53%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $22.13 41.04%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $324.57 91.67%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $545.33 -14.72%
US